Thus, we propose that hypoxia upregulates the expression of Nox4 via the TGF-β/Smad pathway and increases ROS production and therapies targeting Nox4 may be effective against hypoxia-induced acute kidney injury. Here, NOX4 is linked to acute kidney injury.